Target intelligence / Profile preview

Antioxidant defense system enhancement

Molecular classification
Other (biological system; not a single molecule, receptor, or gene)
01

Overview

The antioxidant defense system comprises an array of enzymatic (e.g., superoxide dismutase, catalase, glutathione peroxidase) and non-enzymatic components (e.g., glutathione, vitamins C and E, flavonoids) that protect cells from oxidative damage by neutralizing reactive oxygen species and maintaining redox homeostasis. Enhancement of this system is a therapeutic and preventive strategy for diseases where oxidative stress is implicated, but "antioxidant defense system enhancement" is not a particular target molecule, receptor, or gene—it refers collectively to interventions aimed at improving the overall antioxidant capability of biological tissues. Key caveat: "Antioxidant defense system enhancement" cannot be mapped to a single, canonical molecular target as required by structural bioinformatics or pharmacological ontology. Its improvement involves modulation of numerous genes, proteins, and small molecules within complex biological networks.

Other names
Antioxidant defense systemCellular antioxidant systemOxidative defense system
02

Mechanism of action

Scavenging of ROS directly (non-enzymatic antioxidants); Upregulation of endogenous antioxidant enzymes (via Nrf2 pathway activation); Replenishment of cellular glutathione (GSH) pools; Inhibition of ROS production

03

Biological functions

Neutralization of reactive oxygen speciesMaintenance of redox balanceProtection against oxidative stress-induced damagePrevention of lipid, protein, and DNA oxidation
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationDiabetesOther oxidative stress-related conditions
05

Safety considerations

Non-specificity of interventionsPotential impairment of physiological ROS signalingPossible pro-oxidant effects at high dosages of antioxidantsVariable and sometimes conflicting clinical trial outcomes
06

Interacting drugs

N-acetylcysteine (NAC)

5 more in the full profile.

07

Biomarkers

Glutathione (GSH/GSSG) ratioSuperoxide dismutase (SOD) activityCatalase (CAT) activityGlutathione peroxidase (GPx) activityMalondialdehyde (MDA) levels8-hydroxydeoxyguanosine (8-OHdG)Isoprostanes

Beyond the preview

Go deeper on Antioxidant defense system enhancement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant defense system enhancement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call